2-amino-5-phosphonovalerate and zk 200775

2-amino-5-phosphonovalerate has been researched along with zk 200775 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cebere, A; Cebers, G; Kosowski, AR; Liljequist, S; Swanhagen, AC1

Other Studies

1 other study(ies) available for 2-amino-5-phosphonovalerate and zk 200775

ArticleYear
Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551.
    Psychopharmacology, 2004, Volume: 175, Issue:1

    Topics: 2-Amino-5-phosphonovalerate; Animals; Cell Survival; Cells, Cultured; Cerebellum; Dopamine; Male; Microdialysis; Motor Activity; Nicotine; Nucleus Accumbens; Organophosphonates; Quinoxalines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic; Time Factors

2004
chemdatabank.com